By the Numbers

Stocks on the Move Now

By The Numbers | Stocks on the Move Now

Shares of the following companies are showing unusual moves in Monday's trading session .

Among the winners, Inhibitex is being acquired by Bristol-Myers Squibb for $2.5 billion, which represents a 163 percent premium over Friday's close.

To the downside, Theravance fell on news that Relovair, a GlaxoSmithKline drug developed in the US by Theravance, had some mixed clinical results.